Roche Holding Non-GAAP EPS of CHF 19.46, revenue of CHF 61.52B; issues FY26 outlook
2026-01-29 01:37:52 ET
More on Roche Holding
- Roche's CT-388 Adds Optionality In The GLP Market, But Wait For Dips
- Roche Is The 'Value Play' Of The 2026 Obesity Gold Rush
- Roche: Important De-Risking Of CT-388 In Obesity, Petrelintide Is Next
- Genentech sees strong phase 2 results for obesity treatment CT-388
- Roche more than doubles investment in new North Carolina site
Read the full article on Seeking Alpha
For further details see:
Roche Holding Non-GAAP EPS of CHF 19.46, revenue of CHF 61.52B; issues FY26 outlookNASDAQ: ROCH
ROCH Trading
12.23% G/L:
$28.90 Last:
2,033,245 Volume:
$25.95 Open:



